Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -10.06EBITDA per Share
VS
Market
Sector
Industry
History
$ 4.22Close
$ 4.15 - $ 16.1 52-Week Range
Ticker Information
Ticker
DRMACompany Name
DERMATA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDERMATA THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
DRMA - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -10.33M | $ -10.06 | 1 | 1.03M |
| 3/31/2025 | $ -11.46M | $ -22.23 | 1 | 515.47K |
| 12/31/2024 | $ -12.29M | $ -80.32 | 1 | 152.98K |
| 9/30/2024 | $ -11.27M | $ -72.49 | 1 | 155.47K |
| 6/30/2024 | $ -9.82M | $ -145.09 | 1 | 67.66K |
| 3/31/2024 | $ -8.69M | $ -195.67 | 1 | 44.41K |
| 12/31/2023 | $ -7.79M | $ -399.81 | 1 | 19.5K |
| 9/30/2023 | $ -7.37M | $ -346.77 | 1 | 21.26K |
| 6/30/2023 | $ -8.1M | $ -449.14 | 1 | 18.03K |
| 3/31/2023 | $ -9.13M | $ -1.39K | 1 | 6.57K |
Key Performance Insights, Last 5 Years
- DERMATA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -3.82K.
- Over the past 5 years, DERMATA THERAPEUTICS INC's average EBITDAPS has been $ -1.25K.
- The median EBITDAPS for DERMATA THERAPEUTICS INC during this period was $ -424.47
- DERMATA THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -10.06.
- The lowest EBITDAPS recorded by DERMATA THERAPEUTICS INC in the same timeframe $ -4.38K
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for DERMATA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -3.04M ] / (Shares WA [ 796 ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -3.82K ] DRMA - EBITDA per Share, Last 5 years
$ -4.38K
Minimum
Dec 31, 2021
$ -10.06
Maximum
Jun 30, 2025
$ -1.25K
Average
$ -424.47
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |